Blue Ridge Bankshares (BRBS) is a $2.4B-asset Virginia community bank trading at $3.57, 0.98x tangible book value. In April 2024 it raised $150M from Castle Creek Capital Partners VIII and private investor Kenneth Lehman, who together hold ≈37.5% of shares and three board seats. An OCC consent order from January 2024 was terminated November 13, 2025. The question is whether BRBS is at month 24 of a playbook that runs 21–24 months from PE recap to sale.

What the filings say

The last five months document a compressed capital-return and governance sequence:

• Nov 2025: $0.25/share special dividend (≈$29M).
• Mar 6, 2026: CEO G. William Beale steps down with a structured package totaling ≈$1.55M gross. The retirement agreement includes a 12-month payment schedule and — the key detail — a clause accelerating remaining payments into a lump sum if a change of control is consummated during the payment period. Stated reason: age 76, "hired to do a job, that job is now done." Mutual non-disparagement clause.
• Mar 18, 2026: Harry Golliday, former Chief Credit Officer, appointed Interim CEO and added to the Board.
• Mar 28, 2026: Amendment reduces exercise price on April 2024 warrants dollar-for-dollar by cumulative cash dividends, retroactively. Strike now $1.65 vs $2.50 original.
• Mar 30, 2026: $0.60/share special dividend declared (≈$70M, payable April 27).
• Apr 20, 2026: Board approves Golliday compensation increase to $525K base (+61.5%) and 50% STI cap — permanent-CEO rates — but retains the "Interim" title. Underlying employment agreement is explicitly not amended.

Total returned in five months: ≈$99M, roughly 23% of TBV. Post-consent-order tier 1 leverage is 13.81% vs the prior 10% minimum — capital is in excess of operational needs, and the board is returning it.

What the market thinks

At $3.57 with TBV $3.65, a two-state binomial (deal at 1.55x TBV = $5.66 per the Mid-Atlantic community bank comp set; standalone at 0.85–0.90x TBV ≈ $3.20) solves for market-implied P(M&A) of roughly 15%, with a range of 5–24% depending on the standalone assumption. No liquid options chain, minimal sell-side coverage, no disclosed banker.

Our estimate of P(M&A by Dec 31, 2026): 45%. The edge is approximately 30 percentage points.

Why the gap exists

The information is public; the synthesis is not. The setup requires stacking: (1) April 2024 capital raise terms, (2) PE recap holding conventions — Castle Creek rarely holds past 3 years, Lehman is a bank-specialist investor, (3) OCC consent-order timeline, (4) Mid-Atlantic community bank M&A comps (HBMD→FNB 1.60x TBV, Heartland→UMB 1.40x, FFWM→FirstSun Apr 2026 1.35x distressed), (5) the OCC/FDIC 2024 bank merger guidelines rescinded May–Aug 2025 (regulatory thaw), (6) the change-of-control acceleration clause in Beale's retirement agreement, (7) the warrant ITM cleanup mechanics, and (8) the playbook match — FFWM (21 months from July 2024 recap to April 2026 close), BFIN (≈24 months).

Counterparty is retail and small-cap value; neither is running step 8. Item 5.02 filings draw less attention than 7.01 press releases, and exhibit-level drafting is invisible to momentum. The pattern is a cross-ticker read that hasn't been synthesized.

Risks, ranked

1. Management endorses standalone on April 23 earnings call. Explicit independence commitment re-rates the stock to ≈$3.00. Estimated 12% probability.
2. Two prior failed M&A attempts. FVCB 2022 killed by OCC concerns. "Southern" deal terminated Feb 2024. Execution risk is real.
3. Interim CEO is a credit officer, not a deal executive. Golliday's background doesn't match "hired to sell the bank."
4. Warrant dilution overhang. Strike $1.65 vs ≈$4.00 stock. Remaining outstanding count not disclosed in recent 8-Ks — open gap, resolves via 10-K or next 10-Q.
5. Deal-break risk post-agreement. Regulatory or shareholder rejection after a deal is signed. Roughly 3% probability.
6. Bank M&A closing timeline. 3–6 months from agreement to close even if a deal is reached — horizon-adjusted returns compressed.

Catalysts

• Apr 23, 2026: Q1 2026 earnings call. Strategic alternatives language or banker mention is the binary re-rate. Silent call keeps base case; standalone commitment kills the thesis.
• Apr 27: $0.60 dividend payable.
• Early May: Q1 10-Q — warrant count disclosure, NIM trajectory.
• May–June: 13D amendment window for Castle Creek / Lehman.
• Late July: Q2 earnings.
• Dec 31, 2026: Primary thesis deadline.

What would change our mind

Toward M&A: 13D amendment from either Castle Creek or Lehman with "strategic" or "may explore" language; external banker disclosed on an earnings call; Form 4 open-market purchase (code P) by any director post-earnings; competing regional bank announces Mid-Atlantic acquisition intent.

Toward standalone: permanent CEO named with a multi-year contract and a growth-focused strategic plan; recap investors refile as 13G (passive) rather than 13D (active); additional equity raise >$25M; new OCC supervisory action.

The April 23 call is the first falsification point. Silent call preserves base rate. Explicit commitment resolves the ambiguity in either direction within one trading day.

Evidence

Memo LR: 1.5